Finance

Lists
Why is EW up ၂.၅၅%?
Dive Deeper
EW:NYSE
Edwards Lifesciences Corp
၁၀၄.၇၁ US$
+၂.၅၅%
(+၂.၆၀) 1D
၁၀၄.၇၁ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: နို ၉, GMT-၅ ၁၆:၀၀:၀၄  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EW...
Open
၁၀၂.၈၅ US$
High
၁၀၅.၃၇ US$
Low
၁၀၂.၁၇ US$
Mkt. cap
ဋေ ၆.၀၂ ထ
Avg. vol.
၄.၃၇ သန်း
Volume
၆.၆၈ သန်း
P/E ratio
၅၉.၃၆
52-wk high
၁၀၅.၃၇ US$
52-wk low
၇၄.၆၆ US$
EPS
၁.၇၆ US$
Beta
၀.၈၅
Shares outstanding
၅၇.၅၀ ကုဋေ
No. of employees
၂ သောင်း
Open
၁၀၂.၈၅ US$
High
၁၀၅.၃၇ US$
Low
၁၀၂.၁၇ US$
Mkt. cap
ဋေ ၆.၀၂ ထ
Avg. vol.
၄.၃၇ သန်း
Volume
၆.၆၈ သန်း
P/E ratio
၅၉.၃၆
52-wk high
၁၀၅.၃၇ US$
52-wk low
၇၄.၆၆ US$
EPS
၁.၇၆ US$
Beta
၀.၈၅
Shares outstanding
၅၇.၅၀ ကုဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
Investing.com Canada
Investing.com Canada
·
ပြီးခဲ့သည့် ၄ နာရီ
Form 144 Edwards Lifesciences Corp For: 9 November By Investing.com
News Corp
News Corp
·
ပြီးခဲ့သည့် ၄ နာရီ
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၁၀ နာရီ
Edwards Lifesciences stock rating maintained at Buy by TD Cowen
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၁၈ နာရီ
Edwards Lifesciences CVP Daveen Chopra sells $2.9M in stock
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees၁.၆ သောင်း
Founded၁၉၅၈
Headquartersအိုင်ရာဗင်န်, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Analyst ratings
Based on 23 analysts giving stock ratings to EW in the past 3 months
Strong buy
Buy
20
Hold
3
Sell
0
12-month forecast
Based on 23 Wall Street analysts offering 12 month price targets for EW in the last 3 months.
Highest
Current ၁၀၄.၇၁ US$
၁၂၅.၀၀ US$ (+၁၉.၃၈%)
Average
၁၁၄.၃၀ US$ (+၉.၁၆%)
Lowest
၉၇.၀၀ US$ (-၇.၃၆%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Buy
Maintained
-
-
11/09/2026
Jaret Seiberg
TD Cowen
Buy
Reiterated
၁၁၇.၀၀ US$
+၁၁.၇%
11/09/2026
Unknown Analyst
Oppenheimer
Hold
Maintained
-
-
11/05/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
၁၁၂.၀၀ US$
+၇%
11/05/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
၁၂၀.၀၀ US$
+၁၄.၆%
11/05/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
၁၁၂.၀၀ US$
+၇%
11/05/2026
David Rescott
Robert W. Baird
Buy
Upgraded
၁၁၆.၀၀ US$
+၁၀.၈%
11/05/2026
David Roman
Goldman Sachs
Buy
Maintained
၁၁၅.၀၀ US$
+၉.၈%
11/05/2026
Kendall Au
RBC Capital
Buy
Reiterated
၁၁၅.၀၀ US$
+၉.၈%
11/05/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
၁၁၅.၀၀ US$
+၉.၈%
11/05/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
၁၂၀.၀၀ US$
+၁၄.၆%
11/05/2026
Adam Maeder
Piper Sandler
Buy
Reiterated
၁၁၅.၀၀ US$
+၉.၈%
11/05/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
၁၂၀.၀၀ US$
+၁၄.၆%
11/05/2026
Patrick Wood
UBS
Buy
Reiterated
၁၁၈.၀၀ US$
+၁၂.၇%
11/05/2026
Lee Hambright
Bernstein
Hold
Maintained
၁၀၆.၀၀ US$
+၁.၂%
11/05/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
၁၁၃.၀၀ US$
+၇.၉%
11/05/2026
Joanne Wuensch
Citi
Buy
Reiterated
၁၁၇.၀၀ US$
+၁၁.၇%
11/05/2026
Nico Chen
DBS
Buy
Maintained
၁၂၅.၀၀ US$
+၁၉.၄%
11/05/2026
William Plovanic
Canaccord Genuity
Hold
Maintained
၉၇.၀၀ US$
-၇.၄%
11/05/2026
Christopher Pasquale
Barclays
Buy
Maintained
၁၂၀.၀၀ US$
+၁၄.၆%
11/05/2026
Richard Newitter
Truist Financial
Buy
Upgraded
၁၁၃.၀၀ US$
+၇.၉%
11/03/2026
Chris Krueger CFA
TD Cowen
Buy
Reiterated
၁၁၇.၀၀ US$
+၁၁.၇%
11/05/2026
Josh Jennings
TD Cowen
Buy
Reiterated
၁၁၇.၀၀ US$
+၁၁.၇%
11/03/2026
Marie Thibault
BTIG
Buy
Reiterated
၁၁၀.၀၀ US$
+၅.၁%
10/09/2026
Matt Miksic
Barclays
Buy
Maintained
၁၁၀.၀၀ US$
+၅.၁%
10/07/2026
Tycho Peterson
Jefferies
Buy
Initiated
၁၁၀.၀၀ US$
+၅.၁%
10/07/2026
Matthew Taylor
Jefferies
Buy
Maintained
၁၀၅.၀၀ US$
+၀.၃%
09/11/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
09/10/2026
Suraj Kalia
Oppenheimer
Hold
Maintained
-
-
07/24/2026
Krish Sankar
TD Cowen
Buy
Reiterated
၁၀၄.၀၀ US$
-၀.၇%
06/02/2026
David Toung
Argus Research
Buy
Maintained
-
-
05/21/2026
Michael Polark
Wolfe Research
Buy
Upgraded
၉၂.၀၀ US$
-၁၂.၁%
04/01/2026
Danielle Antalffy
UBS
Hold
Maintained
၉၀.၀၀ US$
-၁၄%
02/12/2026
Last report
၂၀၂၆ နို ၅
Fiscal period
Q3 2026
၀.၈၀ US$ / ၀.၇၄ US$
+၈.၆၂%beat
Revenue / Est. (USD)
၁၇၁.၅၅ ဋေ / ၁၆၇.၆၈ ဋေ
+၂.၃၁%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၁၅၆.၉၆ ဋေ
၁၆၄.၈၆ ဋေ
၁၇၄.၁၀ ဋေ
၁၇၁.၅၅ ဋေ
Cost of goods sold
၃၄.၃၀ ကုဋေ
၃၆.၂၆ ကုဋေ
၃၉.၂၄ ကုဋေ
၃၆.၉၂ ကုဋေ
Cost of revenue
၃၄.၃၀ ကုဋေ
၃၆.၂၆ ကုဋေ
၃၉.၂၄ ကုဋေ
၃၆.၉၂ ကုဋေ
Research and development expenses
၂၆.၇၇ ကုဋေ
၂၆.၃၃ ကုဋေ
၂၇.၈၉ ကုဋေ
၂၈.၁၄ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၆၀.၁၂ ကုဋေ
၅၂.၂၂ ကုဋေ
၅၆.၁၂ ကုဋေ
၅၆.၀၉ ကုဋေ
Operating expense
၈၅.၄၆ ကုဋေ
၇၇.၁၃ ကုဋေ
၈၂.၉၁ ကုဋေ
၈၂.၉၀ ကုဋေ
Total operating expenses
၁၁၉.၇၆ ဋေ
၁၁၃.၃၉ ဋေ
၁၂၂.၁၅ ဋေ
၁၁၉.၈၂ ဋေ
Operating income
၃၇.၂၀ ကုဋေ
၅၁.၄၇ ကုဋေ
၅၁.၉၅ ကုဋေ
၅၁.၇၃ ကုဋေ
Other non operating income
၂.၃၀ သန်း
၆.၉၉ ကုဋေ
-၂.၅၀ ကုဋေ
၂.၅၉ ကုဋေ
EBT including unusual items
၉.၀၄ ကုဋေ
၄၅.၉၀ ကုဋေ
၅၁.၉၈ ကုဋေ
၃၆.၃၂ ကုဋေ
EBT excluding unusual items
၄၆.၄၀ ကုဋေ
၆၀.၃၆ ကုဋေ
၅၁.၁၁ ကုဋေ
၅၆.၀၈ ကုဋေ
Income tax expense
၂.၆၂ ကုဋေ
၇.၈၃ ကုဋေ
၂၇.၈၄ ကုဋေ
၆.၁၈ ကုဋေ
Effective tax rate
၂၈.၉၈%
၁၇.၀၆%
၅၃.၅၆%
၁၇.၀၂%
Other operating expenses
-၁.၄၃ ကုဋေ
-၁.၄၂ ကုဋေ
-၁.၁၀ ကုဋေ
-၁.၃၃ ကုဋေ
Net income
၉.၁၂ ကုဋေ
၃၈.၀၇ ကုဋေ
၂၄.၁၉ ကုဋေ
၃၀.၇၅ ကုဋေ
Net profit margin
၅.၈၁%
၂၃.၀၉%
၁၃.၈၉%
၁၇.၉၂%
Earnings per share
၀.၅၈
၀.၇၈
၀.၇၈
၀.၈၀
Interest and investment income
၁၁.၄၂ ကုဋေ
၁.၇၄ ကုဋေ
၁.၅၀ ကုဋေ
၁.၅၉ ကုဋေ
Interest expense
-၂.၀၄ ကုဋေ
-
-
-
Net interest expenses
၉.၃၈ ကုဋေ
၁.၇၄ ကုဋေ
၁.၅၀ ကုဋေ
၁.၅၉ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၄၁.၄၇ ကုဋေ
၅၅.၅၆ ကုဋေ
၅၆.၂၂ ကုဋေ
၅၆.၂၂ ကုဋေ
Gain or loss from assets sale
-၃.၃၉ ကုဋေ
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ